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In post-genomic era attention has been focused on the 
characterization of the human DNA “methylome” at 
single nucleotide resolution. It is a particularly difficult 
goal to achieve as methylation profiling is different in 
tissues and cells of the same individual. 5-
Methylcytosine is considered the “fifth base” of DNA 
as it introduces an epigenetic code on genome which is 
defined during development. Nutrition, environment 
and style of life have an impact on the “methylome” and 
the introduction of anomalous methyl groups in 
sequences that have to be maintained unmethylated 
and/or demethylation of chromatin regions which are 
usually methylated drive the biological events 
associated with pathologies. The same anomalies in 
methylation patterns occur with age so an in-depth 
knowledge of these changes will help us to individuate 
what leads to the passage from successful ageing to one 
in which there is the onset of disease [1]. Data from 
Franceschi’s group are focused on ageing and the 
cohorts of individuals are selected in order to establish 
whether variability in DNA methylation patterns is to 
ascribe to age of individuals rather than to their 
geographical dimension. Notably, in this study 
monozygotic and dizygotic twins of ages ranging from 
22 to 97 years are also enrolled.  
 
Four regions, located at the Igf2/H19 imprinted locus, 
were analyzed including the CpG island present in 
differentially methylated region 2 (DMR2) and the 
nearby 5’ shore, two fragments never investigated up to 
now. Authors conclude that the shore is the one in 
which the scatter in methylation variability during 
ageing is more evident. 
 
Shore regions, which localize in proximity of CpG 
islands at 200-2000 kb away from them, are of 
particular interest as involved in gene expression 
regulation through the DMRs often located within them 
[2].  
 
A long-range looping interaction is involved in the 
control of imprinting at maternally inherited allele at the 
Igf2/H19 gene locus. An interesting  hypothesis  for  sus- 
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ceptibility to epimutation of this shore region in aged 
individuals is that its position inside the loop is 
topologically responsible for its availability to change 
the methylation profile. Although the higher order 
chromatin organization at Igf2/H19 locus is well 
assessed in mice, less information is available in 
humans.  
 
Anyway, the analysis of data about chromatin structure 
from the ENCODE consortium, accessible at the UCSC 
Genome Browser (http://genome.ucsc.edu/) [3, 4], 
indicates a distinctive chromatin feature of this shore 
region which corresponds to an open, DNAaseI 
hypersensitive chromatin domain characterized by an 
early S-phase replication.   
 
As chromatin structure affects the susceptibility to DNA 
damage, the chromatin shape of the shore could be the 
reason for its susceptibility to epimutation. An 
important link was found between DNA damage, 
homology directed repair and DNA methylation [5], 
suggesting that DNA-methyltransferase 1(DNMT1), 
which is recruited to repair sites following double-
strand DNA breaks [6], marks the repaired segments 
superimposing novel methylation profile.  
 
Another interesting hypothesis rises from the early 
replication timing of this shore. The maintenance of 
DNA methylation patterns during DNA replication 
requires the function of DNMT1 which is brought to the 
replication fork through a direct interaction with 
Proliferating Cell Nuclear Antigen protein (PCNA). 
Interestingly, DNMT1 forms a complex at replication 
foci only during late stages of S-phase when methylated 
DNA is replicated. Thus, the controlled recruitment of 
DNMT1 into replication forks is an important 
component in the perpetuation of DNA methylation 
patterns and S-phase abnormalities could affect 
methylation patterns by altering the replication timing 
of sequences. The biological event able to disrupt 
DNMT1 function in S phase could be poly(ADP-
ribosyl)ation. It has been found that competitive 
inhibition of PARPs leads to hyperexpression of 
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DNMT1 in G1/early S phase, increases the amount of 
DNMT1 that co-immunoprecipitates with PCNA in this 
phase and causes DNA hypermethylation [7]. 
Interestingly, reduced levels of poly(ADP-ribosyl)ation 
enzymes PARP1 and 2 and poly(ADP-ribosyl)ation 
activity have been associated with ageing [8, 9].  
 
In conclusion, changes of methylation profile at Igf2 
CpG island shore observed during ageing could be due 
to the loss of local epigenetic control of this region. The 
understanding of molecular mechanism(s) involved in 
the protection of the methylation pattern of this shore 
could provide important information about the 
participation of epigenetics in ageing and disease. 
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